Gilead Sciences Inc (GILD)
63.33
+0.93 +1.49%
NASDAQ
Jan 15, 20:00
USD
Gilead Sciences Daily Value at Risk (VaR) 1% (All)
View 4,000+ financial data types
Browse...
View Full Chart
Daily Value at Risk (VaR) 1% (All) Chart
Historical Daily Value at Risk (VaR) 1% (All) Data
View and export this data going back to 1992.
Start your Free Trial
Export Data
Date Range:
Data for this Date Range | |
---|---|
Dec. 31, 2020 | Upgrade |
Nov. 30, 2020 | Upgrade |
Oct. 31, 2020 | Upgrade |
Sept. 30, 2020 | Upgrade |
Aug. 31, 2020 | Upgrade |
July 31, 2020 | Upgrade |
June 30, 2020 | Upgrade |
May 31, 2020 | Upgrade |
April 30, 2020 | Upgrade |
March 31, 2020 | Upgrade |
Feb. 29, 2020 | Upgrade |
Jan. 31, 2020 | Upgrade |
Dec. 31, 2019 | Upgrade |
Nov. 30, 2019 | Upgrade |
Oct. 31, 2019 | Upgrade |
Sept. 30, 2019 | Upgrade |
Aug. 31, 2019 | Upgrade |
July 31, 2019 | Upgrade |
June 30, 2019 | Upgrade |
May 31, 2019 | Upgrade |
April 30, 2019 | Upgrade |
March 31, 2019 | Upgrade |
Feb. 28, 2019 | Upgrade |
Jan. 31, 2019 | Upgrade |
Dec. 31, 2018 | Upgrade |
Nov. 30, 2018 | Upgrade |
Oct. 31, 2018 | Upgrade |
Sept. 30, 2018 | Upgrade |
Aug. 31, 2018 | Upgrade |
July 31, 2018 | Upgrade |
June 30, 2018 | Upgrade |
May 31, 2018 | Upgrade |
April 30, 2018 | Upgrade |
March 31, 2018 | Upgrade |
Feb. 28, 2018 | Upgrade |
Jan. 31, 2018 | Upgrade |
Dec. 31, 2017 | Upgrade |
Nov. 30, 2017 | Upgrade |
Oct. 31, 2017 | Upgrade |
Sept. 30, 2017 | Upgrade |
Aug. 31, 2017 | Upgrade |
July 31, 2017 | Upgrade |
June 30, 2017 | Upgrade |
May 31, 2017 | Upgrade |
April 30, 2017 | Upgrade |
March 31, 2017 | Upgrade |
Feb. 28, 2017 | Upgrade |
Jan. 31, 2017 | Upgrade |
Dec. 31, 2016 | Upgrade |
Nov. 30, 2016 | Upgrade |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
View Daily Value at Risk (VaR) 1% (All) for GILD
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.
Start My Free Trial
No credit card required.
Already a subscriber? Sign in.
Advertisement
Daily Value at Risk (VaR) 1% (All) Benchmarks
Regeneron Pharmaceuticals Inc | Upgrade |
Moderna Inc | Upgrade |
Amgen Inc | Upgrade |
Daily Value at Risk (VaR) 1% (All) Range, Past 5 Years
Minimum | Upgrade | Dec 2020 |
Maximum | Upgrade | Apr 2016 |
Average | Upgrade |
News
Gilead provides outlook to mid-to-long term growth strategy at JP Morgan Healthcare Conference
SA Breaking News 01/14 11:24 ET
SA Breaking News 01/14 11:24 ET
Gilead Sciences Working With Vir Biotechnology to Evaluate Therapeutic Combinations Against Hepatitis B
MT Newswires 01/12 08:34 ET
MT Newswires 01/12 08:34 ET
Gilead and VIR Biotechnology tie up in chronic hepatitis B virus cure setting
SA Breaking News 01/12 08:12 ET
SA Breaking News 01/12 08:12 ET
Gilead Sciences Upgrades 2020 Earnings Forecast on Strong Demand for Remdesivir
Yahoo 01/11 11:20 ET
Yahoo 01/11 11:20 ET
Thinking about trading options or stock in Eli Lilly, Gilead Sciences, GameStop, Boeing, or Roku?
PR Newswire 01/11 09:31 ET
PR Newswire 01/11 09:31 ET
Advertisement